On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies

被引:39
|
作者
Hoekstra, CJ
Hoekstra, OS
Lammertsma, AA
机构
[1] Free Univ Amsterdam Hosp, Clin PET Ctr, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Pulm Med, NL-1007 MB Amsterdam, Netherlands
[3] Free Univ Amsterdam Hosp, Dept Clin Epidemiol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1007/s002590050484
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
There is growing interest in monitoring response to therapy in oncology patients using positron emission tomography and fluorine-ls fluorodeoxyglucose (FDG). Quantification is required, and various methods have been described. Arterial sampling, which provides the most accurate input function, often is not feasible in patients undergoing chemotherapy. In the thorax an image-derived input function can be obtained from the large vascular structures. In many studies the left ventricle (LV) is used, but the obtained data are rarely validated. In this study a simple quality control procedure for the image-derived input function was developed and compared with a standard LV curve. Twenty dynamic FDG scans were obtained in nine patients with nonsmall cell lung cancer stage IIIA-N2. Three venous blood samples were taken as a quality control for the image-derived input function. Regions of interest (ROIs) were defined for aorta, LV and left atrium. Input curves were generated according the the standard use of the LV curve and by applying the quality control method to all vascular ROIs. Tumour ROIs were defined and both input functions were used to calculate tumour glucose metabolism (MRglu), using both standard non-linear regression and Patlak analyses. Mean differences in MRglu using "standard" LV and "quality control approved" input functions were 16.2% and 17.5% for non-linear regression and Patlak analyses, respectively, iondicating that the use of "standard" LV curve might lead to significant errors. It is concluded that care should be taken in using image derived input functions without appropriate quality control. The proposed procedure is simple and results in significantly more accurate MRglu data.
引用
收藏
页码:1489 / 1492
页数:4
相关论文
共 50 条
  • [21] Findings on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Patient with Malignant Pheochromocytoma
    Kara, Pelin Ozcan
    Kara, Taylan
    Gedik, Gonca Kara
    Sari, Oktay
    Sahin, Ozlem
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2011, 20 (02) : 67 - 69
  • [22] Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of primary pulmonary angiosarcomas
    Krishnamurthy, Arvind
    Nayak, Deepika
    Ramshankar, Vijayalakshmi
    Majhi, Urmila
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (02): : 142 - 144
  • [23] Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
    Michael T. Osborne
    Edward A. Hulten
    Venkatesh L. Murthy
    Hicham Skali
    Viviany R. Taqueti
    Sharmila Dorbala
    Marcelo F. DiCarli
    Ron Blankstein
    Journal of Nuclear Cardiology, 2017, 24 : 86 - 99
  • [24] Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
    Vidula, Mahesh K.
    Kelly, Daniel P.
    Md, Zoltan Arany
    Margulies, Kenneth B.
    Shah, Svati H.
    Cappola, Thomas P.
    Bravo, Paco E.
    Selvaraj, Senthil
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (12): : 1264 - 1266
  • [25] Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
    Saila Kauhanen
    Camilla Schalin-Jäntti
    Endocrine, 2012, 42 : 461 - 463
  • [26] Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer
    Kosuda, S
    Kison, PV
    Greenough, R
    Grossman, HB
    Wahl, RL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (06) : 615 - 620
  • [27] Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
    Osborne, Michael T.
    Hulten, Edward A.
    Murthy, Venkatesh L.
    Skali, Hicham
    Taqueti, Viviany R.
    Dorbala, Sharmila
    DiCarli, Marcelo F.
    Blankstein, Ron
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 86 - 99
  • [28] The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma
    Jadvar, H
    Johnson, DL
    Segall, GM
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (01) : 48 - 51
  • [29] Fluorine-18 fluorodeoxyglucose positron emission tomography for the detection of recurrent gynecologic cancer.
    Khan, N
    Oriuchi, N
    Kanuma, T
    Higuchi, T
    Miyakubo, M
    Endo, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S329 - S329
  • [30] Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
    Kauhanen, Saila
    Schalin-Jantti, Camilla
    ENDOCRINE, 2012, 42 (03) : 461 - 463